Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

Gilead's 3 Most Profitable Lines of Business
Investopedia
Mon, 03/7/16 - 09:44 am
Tags:
Gilead Sciences, Truvada, Sovaldi, Harvoni, hepatitis C, hepatitis B, HIV
Gilead: Hep C Prescriptions Hold at 94% Among New Patients
Barron's
Fri, 03/4/16 - 02:48 pm
Tags:
Gilead Sciences, hepatitis C, Harvoni, Sovaldi
Gilead Sciences, Inc Widens HIV Lead over GSK with Odefsey’s Approval
Bidness, ETC
Wed, 03/2/16 - 11:47 am
Tags:
Gilead Sciences, HIV, GSK, Odefsey
Gilead's 'R&D Day' Points To Upside For Shareholders
Yahoo/Benzinga
Tue, 03/1/16 - 03:31 pm
Tags:
Gilead Sciences, R&D
His Job Is to Sell a $1,000 Pill for $10 Without Losing Money
Bloomberg
Mon, 02/29/16 - 10:32 am
Tags:
Gilead Sciences, Sovaldi, drug pricing
Gilead Sciences Moves a Step Ahead in HBV Market Gilead Sciences Moves a Step Ahead in HBV Market
Bidness, ETC
Fri, 02/26/16 - 10:28 pm
Tags:
Gilead Sciences, hepatitis B, Europe
Big Pharma Matchup: Valeant vs Gilead
24/7 Wall St
Fri, 02/26/16 - 03:16 pm
Tags:
Valeant Pharmaceuticals, Gilead Sciences
Gilead's HIV drug gets closer to getting Europe approval
Yahoo/Reuters
Fri, 02/26/16 - 10:19 am
Tags:
Gilead Sciences, HIV, Europe, Descovy
J&J sells 5% stake in Galapagos after Gilead usurps it as largest shareholder
Fierce Biotech
Thu, 02/25/16 - 08:43 pm
Tags:
JNJ, Gilead Sciences, Galapagos
TAF-Based HIV Drugs Should Boost Gilead’s Revenue in 2016
Yahoo/Market Realist
Wed, 02/24/16 - 11:47 am
Tags:
Gilead Sciences, HIV, TAF
Gilead Launches New Grants Program to Support HIV Cure
Yahoo
Mon, 02/22/16 - 10:05 am
Tags:
Gilead Sciences, HIV, grants, R&D
A Look Back at 2 Successful Biotech Buyouts
Yahoo/GuruFocus
Mon, 02/22/16 - 09:37 am
Tags:
Gilead Sciences, Pharmasset, Merck, Idenix, M&A
Better Buy: Gilead Sciences Inc. vs. Amgen Inc.
Motley Fool
Sun, 02/21/16 - 11:37 am
Tags:
Gilead Sciences, Amgen
Should Gilead Investors Fear Regulus?
Seeking Alpha
Thu, 02/18/16 - 09:37 am
Tags:
Gilead Sciences, Regulus, hepatitis C, Harvoni, RG-101
Harvoni’s New Label Gives Gilead Edge Over AbbVie
Bidness, ETC
Wed, 02/17/16 - 10:42 am
Tags:
Harvoni, labeling, Gilead Sciences, AbbVie, Viekira Pak, hepatitis C
FDA expands use of Gilead's liver drug to rare subset of patients
Yahoo/Reuters
Tue, 02/16/16 - 10:28 am
Tags:
FDA, Gilead Sciences, Harvoni
AbbVie and Gilead Sciences Lead 2015 Drug Sales with Humira & Harvoni
Bidness, ETC
Thu, 02/11/16 - 09:01 pm
Tags:
AbbVie, Gilead Sciences, Humira, Harvoni
Are the big M&A players in biopharma waiting out the bear market?
Fierce Biotech
Tue, 02/9/16 - 02:15 pm
Tags:
M&A, Roche, Eli Lilly, Gilead Sciences, Sanofi, Biogen
Curing Hepatitis C: How Gilead Sciences Plans to Beat Merck
Motley Fool
Tue, 02/9/16 - 09:21 am
Tags:
hepatitis C, Merck, Gilead Sciences, Zepatier, Harvoni
Is Gilead Sciences Finally Nearing a Bottom?
Motley Fool
Sun, 02/7/16 - 10:42 am
Tags:
Gilead Sciences

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.